Seth Forman

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa

Alexa B. Kimball, Martin M. Okun, David Williams et al. · New England Journal of Medicine · 2016 · 741 citations

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Eric L. Simpson, Rodney Sinclair, Seth Forman et al. · The Lancet · 2020 · 452 citations · Full text

Allergy, Atopic Dermatitis, Medicine +9

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg et al. · New England Journal of Medicine · 2021 · 419 citations · Full text

Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study

Emma Guttman‐Yassky, Jonathan I. Silverberg, Osamu Nemoto et al. · Journal of the American Academy of Dermatology · 2018 · 304 citations

Drug Hypersensitivity, Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis +8

Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies

Kim Papp, Jacek C. Szepietowski, Leon Kircik et al. · Journal of the American Academy of Dermatology · 2021 · 274 citations